SEUIR Repository

Rationally designed DNA therapeutics can modulate human tyrosine hydroxylase expression by controlling specific G-quadruplex formation in its promoter

Files in this item

This item appears in the following Collection(s)

  • Research Articles [916]
    THESE ARE RESEARCH ARTICLES OF ACADEMIC STAFF, PUBLISHED IN JOURNALS AND PROCEEDINGS ELSWHERE

Search SEUIR


Advanced Search

Browse

My Account